Showing results for 
Search instead for 
Did you mean: 
Senior Advisor

More hopeful news for elcheapo


  • Ivermectin is an inhibitor of the COVID-19 causative virus (SARS-CoV-2) in vitro.
  • A single treatment able to effect ∼5000-fold reduction in virus at 48h in cell culture.
  • Ivermectin is FDA-approved for parasitic infections, and therefore has a potential for repurposing.
  • Ivermectin is widely available, due to its inclusion on the WHO model list of essential medicines.

“We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum antiviral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2),” the researchers write. “Ivermectin, therefore, warrants further investigation for possible benefits in humans.”

The leader of the research team, Dr. Kylie Wagstaff issued a statement, saying, “Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective—that’s the next step,” Newsweek magazine reported. “We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it.”

3 Replies
Senior Advisor

Re: More hopeful news for elcheapo

Just to add, 3020 -- they might be able to speed up testing -- it's a drug that is already used, so safety already established at certain dosage levels -- if those already-established maximum dosage levels, or less, will do the job in needed testing in humans -- then it's off to the races.

Veteran Advisor

Re: More hopeful news for elcheapo

From Breitbart - ya. OK - I’m going to pin my hopes on that....